Synageva BioPharma Corp (NASDAQ:GEVA)

98.73
Delayed Data
As of Feb 27
 -0.69 / -0.69%
Today’s Change
60.19
Today|||52-Week Range
122.88
+6.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash--23.9M13.2M--
 
 
 
Short Term Investment Cash45.5M-36.3M38.3M--
 
 
 
 
Cash & Short Term Investments60.2M219.0M408.7M446.9M
 
 
 
 
 
 
ReceivablesReceivables3.5M2.6M2.2M--
 
 
 
 
 
InventoriesInventories0.000.000.00----
 
Current AssetsPrepaid Expenses----4.9M--
 
 
Other Current Assets968.6K3.6M840.0K--
 
 
 
 
Current Assets64.7M225.1M416.7M--
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross3.6M7.3M23.9M--
 
 
 
 
Depreciation-2.4M-3.3M-6.7M--
 
 
 
 
Intangible Assets17.3M14.1M12.0M--
 
 
 
 
Other Assets17.4M14.1M12.1M--
 
 
 
 
Total Assets83.3M243.3M447.9M504.2M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.5M2.6M2.4M--
 
 
 
 
Accrued Expenses1.9M3.3M8.0M--
 
 
 
 
Other Current Liabilities3.6M8.6M8.2M--
 
 
 
 
Other Liabilities8.3M13.1M13.9M--
 
 
 
 
 
Total LiabilitiesOther Liabilities0.000.003.8M--
 
 
Total Liabilities9.2M13.1M17.7M--
 
 
 
 
 
EquityMinority Interest0.000.000.00----
Preferred Stock0.000.000.00----
Common Equity74.0M230.2M430.2M473.2M
 
 
 
 
 
Total Shareholder Equity74.0M230.2M430.2M473.2M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding17.6M24.5M30.8M--
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account